Shares

25 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 11, 2023

BUY
$36.71 - $44.15 $188,359 - $226,533
5,131 Added 0.85%
608,648 $25.3 Million
Q1 2023

May 15, 2023

BUY
$36.81 - $48.12 $407,670 - $532,929
11,075 Added 1.87%
603,517 $24.9 Million
Q4 2022

Feb 13, 2023

SELL
$35.68 - $44.71 $3.71 Million - $4.64 Million
-103,859 Reduced 14.92%
592,442 $24.4 Million
Q3 2022

Nov 14, 2022

SELL
$42.51 - $54.02 $370,559 - $470,892
-8,717 Reduced 1.24%
696,301 $30.5 Million
Q2 2022

Aug 12, 2022

SELL
$46.84 - $59.75 $665,924 - $849,465
-14,217 Reduced 1.98%
705,018 $34.7 Million
Q1 2022

May 13, 2022

SELL
$48.09 - $57.79 $1.37 Million - $1.65 Million
-28,584 Reduced 3.82%
719,235 $40.8 Million
Q4 2021

Feb 08, 2022

SELL
$47.19 - $62.68 $606,297 - $805,312
-12,848 Reduced 1.69%
747,819 $39.2 Million
Q3 2021

Nov 15, 2021

SELL
$56.91 - $67.81 $428,361 - $510,405
-7,527 Reduced 0.98%
760,667 $45.5 Million
Q2 2021

Aug 13, 2021

SELL
$64.02 - $71.72 $369,587 - $414,039
-5,773 Reduced 0.75%
768,194 $52.1 Million
Q1 2021

May 12, 2021

SELL
$53.26 - $68.08 $961,769 - $1.23 Million
-18,058 Reduced 2.28%
773,967 $50.7 Million
Q4 2020

Feb 11, 2021

SELL
$43.41 - $56.51 $904,881 - $1.18 Million
-20,845 Reduced 2.56%
792,025 $44.6 Million
Q3 2020

Nov 16, 2020

SELL
$47.43 - $60.75 $2.29 Million - $2.94 Million
-48,325 Reduced 5.61%
812,870 $39.5 Million
Q2 2020

Aug 14, 2020

BUY
$43.51 - $66.59 $621,540 - $951,238
14,285 Added 1.69%
861,195 $47.9 Million
Q1 2020

May 14, 2020

BUY
$32.82 - $81.13 $205,879 - $508,928
6,273 Added 0.75%
846,910 $42.9 Million
Q4 2019

Feb 14, 2020

SELL
$60.96 - $77.7 $966,337 - $1.23 Million
-15,852 Reduced 1.85%
840,637 $65 Million
Q3 2019

Nov 13, 2019

BUY
$55.78 - $68.08 $920,593 - $1.12 Million
16,504 Added 1.96%
856,489 $54.3 Million
Q2 2019

Aug 13, 2019

BUY
$53.69 - $65.47 $533,249 - $650,248
9,932 Added 1.2%
839,985 $49.2 Million
Q1 2019

May 13, 2019

BUY
$44.53 - $58.9 $465,917 - $616,270
10,463 Added 1.28%
830,053 $47.1 Million
Q4 2018

Feb 12, 2019

SELL
$47.64 - $71.26 $248,442 - $371,620
-5,215 Reduced 0.63%
819,590 $40.6 Million
Q3 2018

Nov 14, 2018

BUY
$52.03 - $71.41 $1.02 Million - $1.39 Million
19,520 Added 2.42%
824,805 $58.5 Million
Q2 2018

Sep 18, 2018

SELL
$48.15 - $56.68 $161,398 - $189,991
-3,352 Reduced 0.41%
805,285 $42 Million
Q2 2018

Aug 14, 2018

BUY
$48.15 - $56.68 $1.13 Million - $1.33 Million
23,422 Added 2.98%
808,637 $42.1 Million
Q1 2018

May 09, 2018

SELL
$46.03 - $61.28 $107,249 - $142,782
-2,330 Reduced 0.3%
785,215 $41 Million
Q4 2017

Feb 14, 2018

SELL
$50.58 - $60.79 $1.67 Million - $2.01 Million
-33,053 Reduced 4.03%
787,545 $46.1 Million
Q3 2017

Nov 13, 2017

BUY
$53.54 - $68.0 $43.9 Million - $55.8 Million
820,598
820,598 $45.5 Million

Others Institutions Holding NUVA

About NUVASIVE INC


  • Ticker NUVA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 52,061,000
  • Description
  • NuVasive, Inc., a medical technology company, develops, manufactures, and sells procedural solutions for spine surgery. It provides surgical access instruments, including Maxcess integrated split-blade retractor system that enable less-invasive surgical techniques by minimizing soft tissue disruption during spine surgery; specialized spinal impl...
More about NUVA
Track This Portfolio

Track Northern Trust Corp Portfolio

Follow Northern Trust Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

News

Stay updated on Northern Trust Corp with notifications on news.